We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Fujitsu Japan has commenced a new research project to detect and analyse potential Covid-19 drugs by leveraging a fast supercomputer, Fugaku, co-developed by the company and RIKEN.
Fujitsu Japan Limited today announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of Research Center for Advanced Science and Technology (RCAST)
GE Healthcare signed on to a new Australian research collaboration to develop artificial intelligence tools to quickly and automatically diagnose brain aneurysms.
Fujitsu brings healthcare to another level with its world-first hands-free speech translation device, leaving healthcare workers' hands free for care tasks.